Table 3 Fugl-Myer Assessment (FMA) of hand function and wrist control and Motricity Index (pinch grip) in the studied groups at baseline, after rESWT, and at follow-up showing significant improvement of FMA in GI after receiving rESWT therapy relative to baseline and in comparison to GII and significant improvement of Motricity Index at follow-up period in GI

 Baseline

1.20 ± 0.17

1.25 ± 0.23

0.436

 After rESWT (2 weeks after the last session)

2.10 ± 0.35

1.30 ± 0.21

< 0.001*

 Follow-up (3 months after the last session)

2.00 ± 0.16

1.35 ± 0.19

< 0.001*

 P1

< 0.001*

0.476

 P2

< 0.001*

0.140

 P3

0.266

0.439

 Baseline

3.65 ± 0.24

3.75 ± 0.32

0.272

 After rESWT (2 weeks after the last session)

5.20 ± 0.36

3.70 ± 0.34

< 0.001*

 Follow-up (3 months after the last session)

4.70 ± 0.18

3.80 ± 0.28

< 0.001*

 P1

< 0.001*

0.632

 P2

< 0.001*

0.600

 P3

< 0.001*

0.313

 Baseline

20.45 ± 3.37

21.05 ± 2.48

0.521

 After rESWT (2 weeks after the last session)

22.70 ± 4.10

21.40 ± 3.23

0.272

 Follow-up (3 months after the last session)

23.15 ± 4.62

21.85 ± .3.70

0.336

 P1

0.064

0.707

 P2

0.043*

0.432

 P3

0.747

0.682